Axim Biotechnologies, Inc.
AXIM· OTC
Filed Mar 4, 2014 · 10-K · 63 days after period end · 0001514955-14-000003
derived · Computed from the longer spans the company filed.
| Metric | Q4 2013dderived from reported figures | Q4 2012dderived from reported figures | Q4 2011dderived from reported figures |
|---|---|---|---|
| Revenue | — | $10.83K | $10.00K |
| Net Income | -$53.80K | -$16.55K | $1.22K |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Axim Biotechnologies, Inc. · CIK 1514946 · Engraved from SEC EDGAR
ended Dec 31, 2013 · filed Mar 4, 2014 · 63 d after period end